Adverse reactions to patent blue V dye - The NEW START and ALMANAC experience

European Journal of Surgical Oncology

Volumn 36, Issue 4, 2010, Pages 399-403

  Barthelmes, L ^a   Goyal, A ^a   Newcombe, R G ^a   McNeill, F ^b   Mansel, R E ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Allergy; Anaphylaxis; Breast cancer; Isosulfan blue; Patent blue V; Sentinel lymph node biopsy

Indexed keywords

DISULFINE BLUE; ISOSULFAN BLUE; TECHNETIUM 99M;

ARTICLE; BODY RASH; BREAST CARCINOMA; BRONCHOSPASM; DRUG FATALITY; HUMAN; HYPOTENSION; LARYNX SPASM; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY; SKIN PRURITUS; TATTOOING; UNSPECIFIED SIDE EFFECT; URTICARIA;

BREAST NEOPLASMS; COLORING AGENTS; DRUG HYPERSENSITIVITY; FEMALE; GREAT BRITAIN; HUMANS; LYMPHATIC METASTASIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; ROSANILINE DYES; SENTINEL LYMPH NODE BIOPSY;

EID: 77949267663     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2009.10.007     Document Type: Article

References (32)

1. Scherer K., Bircher A.J., and Figueiredo V. Blue dyes in medicine-a confusing terminology. Contact Derm 54 4 (2006) 231-232
2. Kalimo K., Jansen C.T., and Kormano M. Sensitivity to patent blue dye during skin-prick testing and lymphography. A retrospective and prospective study. Radiology 141 2 (1981) 365-367
3. Mansel R.E., Fallowfield L., Kissin M., et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst 98 9 (2006) 599-609
4. Montgomery L.L., Thorne A.C., Van Zee K.J., et al. Isosulfan blue dye reactions during sentinel lymph node mapping for breast cancer. Anesth Analg 95 2 (2002) 385-388 table
5. http://www.mhra.gov.uk/home/groups/public/documents/sentineldocuments/dap_1233148728979.pdf. Accessibility checked on 28/02/09.
6. Wohrl S., Focke M., Hinterhuber G., Stingl G., and Binder M. Near-fatal anaphylaxis to patent blue V. Br J Dermatol 150 5 (2004) 1037-1038
7. http://www.nice.org.uk/guidance/CG80. Accessibility checked on 28/02/09.
8. Welsh Cancer Intelligence and Surveillance Unit (2008). Cancer incidence in Wales 1992-2002 (2009), Welsh Cancer Intelligence and Surveillance Unit, Cardiff
9. Office for National Statistics (2008). Cancer statistics registrations: registrations of cancer diagnosed in 2005, England. Series MB1 number 36 (2009), Office for National Statistics, London
10. Raut C.P., Hunt K.K., Akins J.S., et al. Incidence of anaphylactoid reactions to isosulfan blue dye during breast carcinoma lymphatic mapping in patients treated with preoperative prophylaxis: results of a surgical prospective clinical practice protocol. Cancer 104 4 (2005) 692-699
11. Goyal A., Newcombe R.G., Chhabra A., and Mansel R.E. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer-results of the ALMANAC validation phase. Breast Cancer Res Treat 99 2 (2006) 203-208
12. Aydogan F., Celik V., Uras C., Salihoglu Z., and Topuz U. A comparison of the adverse reactions associated with isosulfan blue versus methylene blue dye in sentinel lymph node biopsy for breast cancer. Am J Surg 195 2 (2008) 277-278
13. Pinero A., Illana J., Garcia-Palenciano C., et al. Effect on oximetry of dyes used for sentinel lymph node biopsy. Arch Surg 139 11 (2004) 1204-1207
14. Golshan M., and Nakhlis F. Can methylene blue only be used in sentinel lymph node biopsy for breast cancer?. Breast J 12 5 (2006) 428-430
15. Varghese P., Abdel-Rahman A.T., Akberali S., Mostafa A., Gattuso J.M., and Carpenter R. Methylene blue dye - a safe and effective alternative for sentinel lymph node localization. Breast J 14 1 (2008) 61-67
16. Nour A. Efficacy of methylene blue dye in localization of sentinel lymph node in breast cancer patients. Breast J 10 5 (2004) 388-391
17. Simmons R.M., Smith S.M., and Osborne M.P. Methylene blue dye as an alternative to isosulfan blue dye for sentinel lymph node localization. Breast J 7 3 (2001) 181-183
18. Blessing W.D., Stolier A.J., Teng S.C., Bolton J.S., and Fuhrman G.M. A comparison of methylene blue and lymphazurin in breast cancer sentinel node mapping. Am J Surg 184 4 (2002) 341-345
19. Tsopelas C., and Sutton R. Why certain dyes are useful for localizing the sentinel lymph node. J Nucl Med 43 10 (2002) 1377-1382
20. Salhab M., Al Sarakbi W., and Mokbel K. Skin and fat necrosis of the breast following methylene blue dye injection for sentinel node biopsy in a patient with breast cancer. Int Semin Surg Oncol 2 (2005) 26
21. Ruhlen J.L. Tissue necrosis. Cutaneous and subcutaneous damage following extravasation of methylene blue. J Kans Med Soc 83 5 (1982) 236, 260
22. Perry P.M., and Meinhard E. Necrotic subcutaneous abscesses following injections of methylene blue. Br J Clin Pract 28 8 (1974) 289-291
23. Singh-Ranger G., and Mokbel K. Capsular contraction following immediate reconstructive surgery for breast cancer - an association with methylene blue dye. Int Semin Surg Oncol 1 1 (2004) 3
24. Dewachter P., Mouton-Faivre C., Trechot P., Lleu J.C., and Mertes P.M. Severe anaphylactic shock with methylene blue instillation. Anesth Analg 101 1 (2005) 149-150 table
25. Rzymski P., Wozniak J., Opala T., Wilczak M., and Sajdak S. Anaphylactic reaction to methylene blue dye after laparoscopic chromopertubation. Int J Gynaecol Obstet 81 1 (2003) 71-72
26. Laxenaire M.C. Epidemiology of anesthetic anaphylactoid reactions. Fourth multicenter survey (July 1994-December 1996). Ann Fr Anesth Reanim 18 7 (1999) 796-809
27. Leong S.P., Donegan E., Heffernon W., Dean S., and Katz J.A. Adverse reactions to isosulfan blue during selective sentinel lymph node dissection in melanoma. Ann Surg Oncol 7 5 (2000) 361-366
28. Albo D., Wayne J.D., Hunt K.K., et al. Anaphylactic reactions to isosulfan blue dye during sentinel lymph node biopsy for breast cancer. Am J Surg 182 4 (2001) 393-398
29. Cimmino V.M., Brown A.C., Szocik J.F., et al. Allergic reactions to isosulfan blue during sentinel node biopsy-a common event. Surgery 130 3 (2001) 439-442
30. King T.A., Fey J.V., Van Zee K.J., et al. A prospective analysis of the effect of blue-dye volume on sentinel lymph node mapping success and incidence of allergic reaction in patients with breast cancer. Ann Surg Oncol 11 5 (2004) 535-541
31. Daley M.D., Norman P.H., Leak J.A., et al. Adverse events associated with the intraoperative injection of isosulfan blue. J Clin Anesth 16 5 (2004) 332-341
32. Komenaka I.K., Bauer V.P., Schnabel F.R., et al. Allergic reactions to isosulfan blue in sentinel lymph node mapping. Breast J 11 1 (2005) 70-72